Wall Street brokerages expect that Walgreens Boots Alliance, Inc. (NASDAQ:WBA) will announce $1.22 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Walgreens Boots Alliance’s earnings. The highest EPS estimate is $1.25 and the lowest is $1.20. Walgreens Boots Alliance posted earnings per share of $1.07 during the same quarter last year, which would suggest a positive year over year growth rate of 14%. The company is expected to announce its next quarterly earnings results on Thursday, October 19th.

On average, analysts expect that Walgreens Boots Alliance will report full-year earnings of $5.02 per share for the current year, with EPS estimates ranging from $5.00 to $5.07. For the next financial year, analysts anticipate that the company will report earnings of $5.53 per share, with EPS estimates ranging from $5.39 to $5.74. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research firms that follow Walgreens Boots Alliance.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, topping analysts’ consensus estimates of $1.30 by $0.03. The firm had revenue of $30.12 billion during the quarter, compared to the consensus estimate of $29.72 billion. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The firm’s revenue was up 2.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.18 earnings per share.

A number of research analysts recently commented on the company. Needham & Company LLC set a $94.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Monday, July 17th. Pivotal Research set a $85.00 target price on Walgreens Boots Alliance and gave the company a “hold” rating in a research note on Sunday, July 2nd. Guggenheim restated a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Morgan Stanley restated an “overweight” rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Finally, Citigroup Inc. restated a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and fourteen have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $90.69.

In other news, Director William C. Foote sold 2,736 shares of the stock in a transaction on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total transaction of $218,305.44. Following the sale, the director now owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 13.50% of the stock is currently owned by corporate insiders.

Several hedge funds have recently made changes to their positions in the company. Nordea Investment Management AB boosted its stake in shares of Walgreens Boots Alliance by 26.5% in the first quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator’s stock valued at $760,267,000 after buying an additional 1,917,082 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Walgreens Boots Alliance by 5.9% in the first quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock valued at $2,727,932,000 after buying an additional 1,824,300 shares during the last quarter. American Century Companies Inc. boosted its stake in shares of Walgreens Boots Alliance by 1,145.3% in the second quarter. American Century Companies Inc. now owns 1,304,168 shares of the pharmacy operator’s stock valued at $102,129,000 after buying an additional 1,199,442 shares during the last quarter. TIAA CREF Investment Management LLC boosted its stake in shares of Walgreens Boots Alliance by 22.4% in the first quarter. TIAA CREF Investment Management LLC now owns 5,269,500 shares of the pharmacy operator’s stock valued at $437,632,000 after buying an additional 962,959 shares during the last quarter. Finally, UBS Asset Management Americas Inc. boosted its stake in shares of Walgreens Boots Alliance by 22.9% in the first quarter. UBS Asset Management Americas Inc. now owns 4,912,489 shares of the pharmacy operator’s stock valued at $407,982,000 after buying an additional 914,888 shares during the last quarter. Institutional investors own 61.17% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Brokerages Anticipate Walgreens Boots Alliance, Inc. (NASDAQ:WBA) to Announce $1.22 Earnings Per Share” was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/08/08/brokerages-anticipate-walgreens-boots-alliance-inc-nasdaqwba-to-announce-1-22-earnings-per-share.html.

Walgreens Boots Alliance (NASDAQ:WBA) opened at 81.51 on Tuesday. Walgreens Boots Alliance has a 12-month low of $75.18 and a 12-month high of $88.00. The firm has a market cap of $87.22 billion, a P/E ratio of 20.58 and a beta of 1.25. The firm has a 50-day moving average of $78.82 and a 200-day moving average of $82.40.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.96%. The ex-dividend date is Wednesday, August 16th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio is presently 37.78%.

Walgreens Boots Alliance announced that its Board of Directors has approved a stock repurchase program on Thursday, June 29th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the pharmacy operator to buy up to 5.9% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s board believes its shares are undervalued.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Get a free copy of the Zacks research report on Walgreens Boots Alliance (WBA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.